CAPIVASERTIB | N218197 | ASTRAZENECA PHARMACEUTICALS LP
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8101623 | Mar 10, 2030 | — | Yes | Yes | — | |
| 9487525 | Apr 16, 2033 | — | Yes | Yes | — | — |
| 9492453 | Oct 10, 2028 | — | — | — | — | |
| 10039766 | Apr 16, 2033 | — | — | — | — | |
| 10039766 | Apr 16, 2033 | — | — | — | — | |
| 10059714 | Oct 10, 2028 | — | Yes | Yes | — | — |
| 10654855 | Oct 10, 2028 | — | — | — | — | |
| 11236095 | Oct 10, 2028 | — | — | — | — | |
| 11760760 | Oct 10, 2028 | — | — | — | — | |
| 12252495 | Oct 10, 2028 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| I-991 | Jun 12, 2029 | Active |
| NCE | Nov 16, 2028 | Active |